Matsubara et al. [19] showed that SMARCA4 deletion is more involved in the progression of EGFR wild-type lung cancer but not EGFR-mutant tumors, and it was hypothesized that the coexistence of EGFR mutation and SMARCA4 deletion is not suitable for the survival of tumor cells. This evidence concerns the gene EGFR and lung cancer.